(Q43251106)

English

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients

scientific article published on 30 October 2009

Statements

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients (English)
0 references
0 references
0 references
30 October 2009
94-100

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit